Market Tracker

01/24 2:27pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.06
BATS BZX Real-Time Price
As of 2:26pm ET
 +0.075 / +2.52%
Today’s Change
2.83
Today|||52-Week Range
9.02
-25.12%
Year-to-Date
Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
Jan 17 / Zacks.com - Paid Partner Content
Company News for January 10, 2017
Jan 10 / Zacks.com - Paid Partner Content
Is the Options Market Predicting a Spike in Merrimack (MACK) Stock?
Jan 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.98
Today’s open2.94
Day’s range2.89 - 3.06
Volume83,623
Average volume (3 months)4,134,968
Market cap$386.3M
Dividend yield--
Data as of 2:26pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+12.28%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.20+2.19%
MYOKMyoKardia Inc-0.25-2.15%
FOMXFoamix Pharmaceutica...0.000.00%
SPPISpectrum Pharmaceuti...+0.01+0.22%
Data as of 2:27pm ET, 01/24/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gary L. Crocker
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts